Last reviewed: June 8, 2026

Last updated: June 8, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide works by slowing stomach emptying and signaling fullness to your brain, which means finding your right dose is a gradual process tailored to your body's response. Most people start at 0.25 mg weekly and increase over 4–12 weeks based on hunger reduction and side effect tolerance. PlexusDx provides compounded semaglutide from licensed 503A pharmacies, with pricing that stays flat regardless of your final dose strength.

Start your GLP-1 program with PlexusDx

One all-inclusive price covers your online provider visit, prescription, compounded medication, and shipping — no membership, no hidden fees. Complete a short intake and a licensed provider takes it from there.

Start your intake →

Understanding Semaglutide Starting Doses for Weight Loss

The typical semaglutide weight loss protocol begins at 0.25 mg injected once per week under the skin. This low starting dose allows your body to adapt to the medication while minimizing nausea and digestive side effects that can occur in early weeks. Your prescribing provider monitors your response during this phase and plans for gradual increases.

Increasing your semaglutide dose happens in structured steps, usually at intervals set by your prescriber, commonly about every 4 weeks, moving from 0.25 mg up to 0.5 mg, then 1.0 mg, and potentially to 2.4 mg over several weeks. The goal is not to reach the highest dose, but to find the dose level where you experience meaningful hunger reduction and weight loss without intolerable side effects. Some patients reach their target dose in 4 weeks; others take 12 weeks or longer.

How Your Body Responds to Dose Increases

When you increase semaglutide, your GLP-1 receptors become more activated, which strengthens signals from your gut telling your brain you are full. This effect typically becomes noticeable within 3–5 days of a dose increase, and many people report eating less and feeling satisfied with smaller portions. Changes in appetite suppression and weight loss trajectory help your provider decide whether to continue increasing or hold at your current dose.

The PlexusDx Precision Peptide Genetic Test reports on variants that relate to GLP-1 and related signaling pathways. It does not predict your response to Ozempic or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

Maintenance Doses and Long-Term Weight Loss

Most patients reach a maintenance dose between 1.0 mg and 2.4 mg per week, where their hunger suppression is robust and weight loss continues at a healthy pace without excessive side effects. Maintenance does not mean you stop there forever—some people remain at 1.0 mg for excellent results, while others need 2.0 or 2.4 mg to sustain their progress. Your provider adjusts based on your ongoing hunger levels, eating patterns, and weight loss results.

The critical principle with semaglutide dosing is that your dose may need to go up over time as your body adjusts, but your monthly cost with PlexusDx stays the same. Unlike insurance-based models where higher doses cost more, PlexusDx compounded semaglutide injections are $189/mo month-to-month, or from $149/mo on the 6-month plan across all dose strengths, removing financial barriers to finding your optimal therapeutic level.

Choosing Between Injection and Oral Semaglutide Options

Compounded semaglutide injections deliver the medication directly under the skin once weekly, achieving faster absorption and higher bioavailability than oral forms. Injected semaglutide typically shows stronger appetite suppression and more predictable weight loss responses, which is why many patients and providers prefer this route for initial therapy. PlexusDx compounded semaglutide injections are $189/mo month-to-month, or from $149/mo on the 6-month plan and are prepared by licensed 503A compounding pharmacies serving all 50 states.

Oral semaglutide tablets offer convenience and needle-free dosing, though they require specific timing on an empty stomach to maximize absorption and are often less potent than injections. PlexusDx oral semaglutide is $289/mo month-to-month, or from $249/mo on the 6-month plan and works well for patients who prefer tablets or have needle anxiety. Your provider helps determine which format aligns best with your lifestyle, adherence patterns, and weight loss goals.

Genetic Testing and Personalized Semaglutide Dosing Strategy

The PlexusDx Precision Peptide Genetic Test analyzes FTO — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to semaglutide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

The PlexusDx Precision Peptide Genetic Test ($298) analyzes GIPR — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to semaglutide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $298 to personalize your protocol from day one.

Frequently Asked Questions

What dose of semaglutide should I start for weight loss?

Standard starting dose is 0.25 mg injected once weekly under the skin. This low dose minimizes early side effects while allowing your body to adapt to the medication. Your provider will plan dose increases over 4–12 weeks based on your hunger reduction and tolerance.

How long does it take to reach my target semaglutide dose?

Most patients reach their effective maintenance dose within 4–12 weeks, though some take longer. The timeline depends on how your body tolerates each increase and how quickly you see hunger reduction and weight loss. Patience during this titration phase leads to better long-term outcomes.

Will my semaglutide cost more if I need a higher dose?

No. PlexusDx compounded semaglutide injections are $189/mo month-to-month, or from $149/mo on the 6-month plan flat, regardless of your final dose strength. Your dose may increase, but your price stays the same—removing cost barriers to finding your optimal therapeutic level.

What is the maximum safe dose of semaglutide for weight loss?

The highest studied dose is 2.4 mg weekly, though many patients achieve excellent weight loss at 1.0–2.0 mg per week. Your provider determines your maximum based on your response and tolerance, not on a fixed ceiling. Going higher than your effective dose increases side effect risk without additional benefit.

How does the Precision Peptide Genetic Test relate to your GLP-1 pathway?

No — the Precision Peptide Genetic Test does not predict your response to semaglutide or any specific medication. It analyzes pathway-level variants that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Is compounded semaglutide safe and effective as brand-name versions?

Compounded semaglutide is prepared by licensed 503A compounding pharmacies under strict quality standards and uses the same pharmaceutical-grade active ingredient as brand-name products. Studies show compounded GLP-1 medications deliver comparable clinical results at a lower cost.

Related Reading

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake

~60 seconds · $0 charged until your provider approves